By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

True North Therapeutics  

951 Gateway Boulevard

South San Francisco  Califonia  94080  U.S.A.
Phone: 650-872-4700 Fax: n/a


SEARCH JOBS




Key Statistics


Email: info@truenorth.com
Ownership: Private

Web Site: True North Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
True North Therapeutics Appoints Pamela M. Wapnick As Chief Financial Officer 8/2/2016 11:29:47 AM
True North Therapeutics To Present Clinical Data In Patients With Cold Agglutinin Disease (CAD) For Lead Product Candidate TNT009 6/13/2016 10:49:48 AM
True North Therapeutics ’s Lead Product Candidate, TNT009, Demonstrates High Response Rates And Rapid Onset Of Action In Interim Clinical Data In Patients With Cold Agglutinin Disease (CAD) 6/13/2016 10:23:19 AM
True North Therapeutics To Present Clinical Data In Patients With Cold Agglutinin Disease (CAD) For Lead Product Candidate TNT009 5/19/2016 12:21:58 PM
True North Therapeutics Launches COMPASS Registry To Advance Development Of New Therapeutics For Patients With Cold Agglutinin Disease (And Other Autoimmune Hemolytic Anemias) 3/8/2016 9:28:39 AM
True North Therapeutics Receives Orphan Drug Designation In The European Union For TNT009 For The Treatment Of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD) 2/25/2016 9:48:39 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
True North Therapeutics To Present Clinical Data For Lead Product Candidate At J.P. Morgan Healthcare Conference 1/5/2016 11:32:27 AM
True North Therapeutics Presents Data In Patients With Cold Agglutinin Disease (CAD) Supporting Patient Profiles For TNT009 Phase Ib Study 12/7/2015 11:14:48 AM
With Almost $100 Million in Financing, Bay Area’s True North Therapeutics Jumps Into Immune System Clinical Trials 12/3/2015 6:01:01 AM
12
//-->